Koç University
Clinical trials sponsored by Koç University, explained in plain language.
-
Brain-Training games tested as a tool for intellectual disabilities
Disease control Recruiting nowThis study tests whether playing digital brain games on the MentalUP app can improve visual memory and cognitive skills in young adults (18-35) with mild to moderate intellectual disabilities. Sixty participants will be split into two groups: one plays the games, the other contin…
Phase: NA • Sponsor: Koç University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New nerve block could cut opioid use for kidney donors
Symptom relief Recruiting nowThis study tests whether a nerve block called the transversalis fascia plane block can reduce pain and opioid use after hand-assisted laparoscopic donor nephrectomy. Fifty living kidney donors will be randomly assigned to receive either standard anesthesia alone or standard anest…
Phase: NA • Sponsor: Koç University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Peer lessons could cool climate anxiety in future nurses
Knowledge-focused Recruiting nowThis study looks at whether teaching nursing students about climate change through peer-led sessions can increase their awareness and reduce their anxiety about it. Researchers will measure changes before and after the education. The goal is to see if this approach helps future n…
Phase: NA • Sponsor: Koç University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Shoulder pain breakthrough? MRI map may guide better care
Knowledge-focused Recruiting nowThis study is creating a new classification system for shoulder calcific tendinitis based on MRI scans. Researchers will look at 400 patients to see if the location of calcium deposits relates to which treatment works best. The goal is to help doctors choose between conservative …
Sponsor: Koç University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Could a protein called VISTA be the key to understanding MS?
Knowledge-focused Recruiting nowThis study compares levels of a protein called VISTA in immune cells from people with multiple sclerosis (MS) or clinically isolated syndrome (CIS) and healthy volunteers. Researchers will take blood samples at the first attack and again at 6 and 12 months to see if VISTA levels …
Sponsor: Koç University • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:34 UTC